3 December 2015

Director Dealing

VERONA PHARMA PLC - Director Dealing

Read more

1 December 2015

Holding(s) in Company

 

Read more

11 November 2015

RPL554 paper published in American Journal of Physiology

VERONA PHARMA PLC - RPL554 paper published in American Journal of Physiology

Read more

5 November 2015

Patient enrolment completed in RPL554 PhIIa studies

VERONA PHARMA PLC - Patient enrolment completed in RPL554 PhIIa studies

Read more

14 October 2015

Start of RPL554 Phase IIa combination study

VERONA PHARMA PLC - Start of RPL554 Phase IIa combination study

Read more

8 October 2015

RPL554 data presented at North American CF Conference

VERONA PHARMA PLC - RPL554 data presented at North American CF Conference

Read more

29 September 2015

Positive headline data from RPL554 study

VERONA PHARMA PLC - Positive headline data from RPL554 study

Read more

8 September 2015

Board Changes

VERONA PHARMA PLC - Board Changes

Read more

8 September 2015

Half-yearly Report

VERONA PHARMA PLC - Half-yearly Report

Read more

27 August 2015

Notice of Results

VERONA PHARMA PLC - Notice of Results

Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us